The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells

Steve Goodison, Jing Yuan, Derek Sloan, Ryung S. Kim, Cheng Li, Nicholas C. Popescu, Virginia Urquidi

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

The identification of molecular signatures characteristic of tumor cells that are capable of metastatic spread is required for the development of therapeutic interventions to abrogate this lethal process. To facilitate this, we have previously characterized an experimental system in which the role of candidate metastasis-related genes can be screened and tested. Monoclonal cell lines M4A4 and NM2C5 are spontaneously occurring sublines of the MDA-MB-435 cell breast tumor cell line that exhibit phenotypic differences in growth, invasion, and metastatic efficiency in athymic mice. In this study, transcriptional profiles of these cell lines were created using oligonucleotide microarrays representing over 12,000 genes. Intensity modeling and hierarchical clustering analysis identified a 171-gene expression signature that correlated with metastatic phenotype and highlighted several GTPase signaling components. Restoration of one of these GTPases, deleted in liver cancer-1 (DLC-1), in metastatic M4A4 cells to levels observed in the nonmetastatic NM2C5 cell line resulted in the inhibition of migration and invasion in vitro and a significant reduction in the ability of these cells to form pulmonary metastases in athymic mice. These studies show the utility of expression profiling, in an appropriate experimental system, to identify genetic determinants of metastatic sufficiency. The finding that DLC-1 can act as a metastasis-suppressor gene supports an influential role for GTPase signaling in tumor progression.

Original languageEnglish (US)
Pages (from-to)6042-6053
Number of pages12
JournalCancer Research
Volume65
Issue number14
DOIs
StatePublished - Jul 15 2005
Externally publishedYes

Fingerprint

Liver Neoplasms
GTP Phosphohydrolases
Breast Neoplasms
Neoplasm Metastasis
Nude Mice
Cell Line
Proteins
Oligonucleotide Array Sequence Analysis
Tumor Cell Line
Tumor Suppressor Genes
Transcriptome
Genes
Cluster Analysis
Neoplasms
Phenotype
Lung
Growth
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Goodison, S., Yuan, J., Sloan, D., Kim, R. S., Li, C., Popescu, N. C., & Urquidi, V. (2005). The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Research, 65(14), 6042-6053. https://doi.org/10.1158/0008-5472.CAN-04-3043

The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. / Goodison, Steve; Yuan, Jing; Sloan, Derek; Kim, Ryung S.; Li, Cheng; Popescu, Nicholas C.; Urquidi, Virginia.

In: Cancer Research, Vol. 65, No. 14, 15.07.2005, p. 6042-6053.

Research output: Contribution to journalArticle

Goodison, S, Yuan, J, Sloan, D, Kim, RS, Li, C, Popescu, NC & Urquidi, V 2005, 'The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells', Cancer Research, vol. 65, no. 14, pp. 6042-6053. https://doi.org/10.1158/0008-5472.CAN-04-3043
Goodison, Steve ; Yuan, Jing ; Sloan, Derek ; Kim, Ryung S. ; Li, Cheng ; Popescu, Nicholas C. ; Urquidi, Virginia. / The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. In: Cancer Research. 2005 ; Vol. 65, No. 14. pp. 6042-6053.
@article{c68ba4245116439b970332bda296fa1b,
title = "The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells",
abstract = "The identification of molecular signatures characteristic of tumor cells that are capable of metastatic spread is required for the development of therapeutic interventions to abrogate this lethal process. To facilitate this, we have previously characterized an experimental system in which the role of candidate metastasis-related genes can be screened and tested. Monoclonal cell lines M4A4 and NM2C5 are spontaneously occurring sublines of the MDA-MB-435 cell breast tumor cell line that exhibit phenotypic differences in growth, invasion, and metastatic efficiency in athymic mice. In this study, transcriptional profiles of these cell lines were created using oligonucleotide microarrays representing over 12,000 genes. Intensity modeling and hierarchical clustering analysis identified a 171-gene expression signature that correlated with metastatic phenotype and highlighted several GTPase signaling components. Restoration of one of these GTPases, deleted in liver cancer-1 (DLC-1), in metastatic M4A4 cells to levels observed in the nonmetastatic NM2C5 cell line resulted in the inhibition of migration and invasion in vitro and a significant reduction in the ability of these cells to form pulmonary metastases in athymic mice. These studies show the utility of expression profiling, in an appropriate experimental system, to identify genetic determinants of metastatic sufficiency. The finding that DLC-1 can act as a metastasis-suppressor gene supports an influential role for GTPase signaling in tumor progression.",
author = "Steve Goodison and Jing Yuan and Derek Sloan and Kim, {Ryung S.} and Cheng Li and Popescu, {Nicholas C.} and Virginia Urquidi",
year = "2005",
month = "7",
day = "15",
doi = "10.1158/0008-5472.CAN-04-3043",
language = "English (US)",
volume = "65",
pages = "6042--6053",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "14",

}

TY - JOUR

T1 - The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells

AU - Goodison, Steve

AU - Yuan, Jing

AU - Sloan, Derek

AU - Kim, Ryung S.

AU - Li, Cheng

AU - Popescu, Nicholas C.

AU - Urquidi, Virginia

PY - 2005/7/15

Y1 - 2005/7/15

N2 - The identification of molecular signatures characteristic of tumor cells that are capable of metastatic spread is required for the development of therapeutic interventions to abrogate this lethal process. To facilitate this, we have previously characterized an experimental system in which the role of candidate metastasis-related genes can be screened and tested. Monoclonal cell lines M4A4 and NM2C5 are spontaneously occurring sublines of the MDA-MB-435 cell breast tumor cell line that exhibit phenotypic differences in growth, invasion, and metastatic efficiency in athymic mice. In this study, transcriptional profiles of these cell lines were created using oligonucleotide microarrays representing over 12,000 genes. Intensity modeling and hierarchical clustering analysis identified a 171-gene expression signature that correlated with metastatic phenotype and highlighted several GTPase signaling components. Restoration of one of these GTPases, deleted in liver cancer-1 (DLC-1), in metastatic M4A4 cells to levels observed in the nonmetastatic NM2C5 cell line resulted in the inhibition of migration and invasion in vitro and a significant reduction in the ability of these cells to form pulmonary metastases in athymic mice. These studies show the utility of expression profiling, in an appropriate experimental system, to identify genetic determinants of metastatic sufficiency. The finding that DLC-1 can act as a metastasis-suppressor gene supports an influential role for GTPase signaling in tumor progression.

AB - The identification of molecular signatures characteristic of tumor cells that are capable of metastatic spread is required for the development of therapeutic interventions to abrogate this lethal process. To facilitate this, we have previously characterized an experimental system in which the role of candidate metastasis-related genes can be screened and tested. Monoclonal cell lines M4A4 and NM2C5 are spontaneously occurring sublines of the MDA-MB-435 cell breast tumor cell line that exhibit phenotypic differences in growth, invasion, and metastatic efficiency in athymic mice. In this study, transcriptional profiles of these cell lines were created using oligonucleotide microarrays representing over 12,000 genes. Intensity modeling and hierarchical clustering analysis identified a 171-gene expression signature that correlated with metastatic phenotype and highlighted several GTPase signaling components. Restoration of one of these GTPases, deleted in liver cancer-1 (DLC-1), in metastatic M4A4 cells to levels observed in the nonmetastatic NM2C5 cell line resulted in the inhibition of migration and invasion in vitro and a significant reduction in the ability of these cells to form pulmonary metastases in athymic mice. These studies show the utility of expression profiling, in an appropriate experimental system, to identify genetic determinants of metastatic sufficiency. The finding that DLC-1 can act as a metastasis-suppressor gene supports an influential role for GTPase signaling in tumor progression.

UR - http://www.scopus.com/inward/record.url?scp=22244443056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22244443056&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-3043

DO - 10.1158/0008-5472.CAN-04-3043

M3 - Article

C2 - 16024604

AN - SCOPUS:22244443056

VL - 65

SP - 6042

EP - 6053

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 14

ER -